Breaking News, Promotions & Moves

CMC Biologics Appoints GM

Wypych to manage clinical and commercial manufacturing ops

Joseph Wypych has been appointed general manager of CMC Biologics’ Seattle facility. Mr. Wypych will manage site operations of the company’s clinical and commercial manufacturing facility.
 
Mr. Wypych brings more than 20 years of biopharma industry expertise in process development and manufacturing. He joins the company from Baxter Bioscience, where he served as Plant Manager at Hayward, CA. Previously, he held manufacturing and supply chain project management positions at ImClone Systems and Cell Genesys Inc., respectively.
 
“Joseph brings significant manufacturing and business experience in operations and materials management of clinical and commercial biopharmaceuticals,” said Gustavo Mahler, chief operations officer of CMC Biologics. “His results-oriented approach and focus on people will play a pivotal role in growing our business and strengthening our company culture.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters